Biopsies have long been the gold standard diagnostic tool in medicine, a trusted window into the body’s most guarded secrets. For more than a century, the formula has barely changed: take a piece of tissue, place it on a slide, stain it, and rely on a pathologist’s expert eye to decode what’s really happening inside. …
Continue reading “The Evolution and Future of Biopsies: From Cutting Tissue to Decoding Data”
On November 10, 2025, the U.S. Food and Drug Administration announced it was removing the long-standing “black box” warning from many menopausal hormone replacement therapy (HRT) labels. For many women, that warning created fear and confusion about whether hormones are “too risky,” even when facing unmanageable symptoms.Menopausal HRT involves taking estrogen, with or without a …
Continue reading “When Labels Change but Confusion Remains: Supporting Women Through HRT’s New Era”
Imagine opening an email from your regional public health authority – or perhaps you don’t have to imagine at all. Many of us with school-aged children in Ontario have received one recently, a stark reminder of how fragile our sense of safety can feel when public trust in preventive care begins to waver. “Dear Parent/Guardian, …
Continue reading “What Happens When Healthcare Communications Break Down?”
Chronic insomnia affects millions of people, and it’s far more than just a frustrating night or two without sleep. For those who experience it, insomnia becomes a relentless cycle: the desperation to sleep intensifies anxiety, which makes sleep even harder to achieve. This is exactly what happened to my adult son during a particularly stressful …
In our last article, we discussed how “Healthy Aging” is emerging as a new, targeted therapeutic area. Among the most surprising candidates showing promise in this field are glucagon-like peptide-1 receptor agonists (GLP-1 RAs) – medications originally developed to target diabetes. Research into GLP-1 RAs has an interesting history that started back in the early …
Continue reading “Could GLP-1 Receptor Agonists Become the First True “Longevity-Enhancing” Drugs?”